Suchergebnisse - "Busacca, Anita"

PubPharm (12)

1

SPOSAB ABP 501 : A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

enthalten in: Journal of gastroenterology and hepatology | 2021

von Macaluso, F. | Cappello, M. | Busacca, A. | +23

2

Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cucchetti, A. | Gramenzi, A. | Johnson, P. | +94

3

Pattern of macrovascular invasion in hepatocellular carcinoma

enthalten in: European journal of clinical investigation | 2021

von Guarino, M. | Cucchetti, A. | Pontillo, G. | +90

4

Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Celsa, C. | Cabibbo, G. | Enea, M. | +9

CommentIn: Liver Int. 2021 May;41(5):891-893. - PMID 33861895

5

The Course of COVID-19 in Inflammatory Bowel Disease : Protective Role of TNF Antagonists

enthalten in: Gastroenterology | 2021

von Cappello, M. | Busacca, A. | Guida, L.

CommentOn: Gastroenterology. 2020 Aug;159(2):481-491.e3. - PMID 32425234

6

Perception of the Role of Food and Dietary Modifications in Patients with Inflammatory Bowel Disease : Impact on Lifestyle

enthalten in: Nutrients | 2021

von Guida, L. | Di Giorgio, F. | Busacca, A. | +5

7

Systemic therapies for hepatocellular carcinoma : the present and the future

enthalten in: Recenti progressi in medicina | 2021

von Celsa, C. | Giuffrida, P. | Stornello, C. | +8

8

Monofocal hepatocellular carcinoma : How much does size matter?

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Pelizzaro, F. | Penzo, B. | Peserico, G. | +87

9

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease

enthalten in: Journal of gastroenterology and hepatology | 2021

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +19

10

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease

enthalten in: Journal of Gastroenterology and Hepatology | 2021

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +18